A low prostate specific antigen predicts a worse outcome in high but not in low/intermediate-grade prostate cancer.

Fankhauser CD, Parry MG, Ali A, Cowling TE, Nossiter J, Sujenthiran A, Berry B, Morris M, Aggarwal A, Payne H, van der Meulen J